This is the authors' abstract. We don't add key points for this paper.
Bronchiectasis (BE) is a chronic and progressive respiratory disease with multiple possible causes [1, 2]. Many require a specific therapy and thus, a systematic aetiologic evaluation is recommended by guidelines [3]. Studies have shown wide heterogeneity in the proportion of different aetiologies identified among centres [4–8], which can be partially justified because of geographical risks factors, but may also reflect variations in testing practice or in the definitions of aetiology used [9]. The proportion of patients classified as idiopathic varies (26–74%) across the literature, and this variability is likely to be somewhat linked to a lack of use of a standard aetiological algorithm [4–8]. The use of a standardised aetiological algorithm in bronchiectasis can improve the diagnosis of underlying cause
No takes yet. Share an insight, caveat, or question.
Araújo et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: